Holdings Channel
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree ENT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the ENT Insider Buying occurred are:

RLH Insider Buying
REPL Insider Buying
TNAV Insider Buying
PRED Insider Buying
TAGS Insider Buying
SMTX Insider Buying
BCEI Insider Buying
CKPT Insider Buying
CCSB Insider Buying
ACY Insider Buying

ENT insider buying image
The table below summarizes the most recent ENT insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ENT insider buys are important for investors to follow.
DateInsiderPriceAmount
11-21-2019
Insider Buy
Joshua Marks
Chief Executive Officer
$0.45
CAGR »
$8,958.00
20,000 shares
8-27-2019
Insider Buy
Robert W. Reding
Director
$0.61
CAGR »
$15,250.00
25,000 shares
8-19-2019
Insider Buy
Ronald Steger
Director
$0.66
CAGR »
$33,000.00
50,000 shares
6-5-2019
Insider Buy
Ronald Steger
Director
$0.50
CAGR »
$100,500.00
200,000 shares
6-7-2019
Insider Buy
Jeffrey A. Leddy
Executive Chairman
$0.54
CAGR »
$216,000.00
400,000 shares
6-5-2019
Insider Buy
Searchlight II TBO-W, L.P.
>10% Owner
$0.30
CAGR »
$1,500,000.00
5,000,000 shares
6-5-2019
Insider Buy
Eric Louis Zinterhofer
Director
$0.30
CAGR »
$1,500,000.00
5,000,000 shares
5-29-2019
Insider Buy
Robert W. Reding
Director
$0.73
CAGR »
$14,600.00
20,000 shares
5-23-2019
Insider Buy
Per Noren
President
$0.85
CAGR »
$5,110.20
6,012 shares
5-20-2019
Insider Buy
Robert W. Reding
Director
$1.00
CAGR »
$25,000.00
25,000 shares
5-20-2019
Insider Buy
Harry Sloan
Director
$1.03
CAGR »
$5,356.00
5,200 shares
5-17-2019
Insider Buy
Jeffrey A. Leddy
Executive Chairman
$1.15
CAGR »
$57,500.00
50,000 shares
5-17-2019
Insider Buy
Joshua Marks
Chief Executive Officer
$1.09
CAGR »
$10,900.00
10,000 shares
6-1-2018
Insider Buy
Jeffrey Sagansky
Director
$2.38
CAGR »
$59,375.00
25,000 shares
5-24-2018
Insider Buy
Per Noren
EVP, Chief Commercial Officer
$1.96
CAGR »
$11,197.48
5,713 shares
5-22-2018
Insider Buy
Eric Sondag
Director
$1.81
CAGR »
$1,948,369.49
1,078,594 shares
5-22-2018
Insider Buy
Eric Louis Zinterhofer
Director
$1.81
CAGR »
$1,948,369.49
1,078,594 shares
5-22-2018
Insider Buy
Searchlight II TBO-W, L.P.
>10% Owner
$1.81
CAGR »
$1,948,369.49
1,078,594 shares
5-18-2018
Insider Buy
Joshua Marks
Chief Executive Officer
$1.25
CAGR »
$21,250.00
17,000 shares
5-21-2018
Insider Buy
Harry Sloan
Director
$1.59
CAGR »
$398,450.00
250,000 shares
5-17-2018
Insider Buy
Ronald Steger
Director
$1.02
CAGR »
$25,610.00
25,000 shares
5-18-2018
Insider Buy
Edward Shapiro
Director
$1.36
CAGR »
$135,810.00
100,000 shares
5-18-2018
Insider Buy
Harry Sloan
Director
$1.38
CAGR »
$345,275.00
250,000 shares
5-18-2018
Insider Buy
Eric Sondag
Director
$1.20
CAGR »
$683,002.80
568,800 shares
5-18-2018
Insider Buy
Eric Louis Zinterhofer
Director
$1.20
CAGR »
$683,002.80
568,800 shares
5-17-2018
Insider Buy
Robert W. Reding
Director
$1.00
CAGR »
$3.00
3 shares
5-18-2018
Insider Buy
Wale Adepoju
EVP, Chief Strategy Officer
$1.37
CAGR »
$25,324.65
18,500 shares
5-17-2018
Insider Buy
Jeffrey A. Leddy
Executive Chairman
$1.15
CAGR »
$100,927.20
88,000 shares
5-17-2018
Insider Buy
Joshua Marks
Chief Executive Officer
$1.08
CAGR »
$62,396.40
58,000 shares
5-18-2018
Insider Buy
Per Noren
EVP, Chief Commercial Officer
$1.36
CAGR »
$40,920.00
30,000 shares

Also See: Institutional Holders of ENT
Also See: SEC filings

ENT Performance Since Insider Purchase
Below we present the annualized performance delivered by ENT stock since 11-21-2019 (the date of the most recent insider purchase). The performance of the investment from the time ENT insider buying occurred is the ultimate test of whether insiders were right about ENT being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/22/2019
End date: 08/03/2020
Start price/share: $11.50
End price/share: $1.90
Dividends collected/share: $0.00
Total return: -83.48%
Annualized Gain: -119.96%
Starting investment: $10,000.00
Ending investment: $1,652.00
Years: 0.70

ENT Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ENT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ENT

ENT Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.